18834540

Source:http://linkedlifedata.com/resource/pubmed/id/18834540

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0012655, umls-concept:C0069515, umls-concept:C0242957, umls-concept:C0338204, umls-concept:C0392756, umls-concept:C1333928, umls-concept:C1512505, umls-concept:C2350440
pubmed:dateCreated	2008-10-15
pubmed:abstractText	Elucidating the molecular mechanisms by which tumors become resistant to Herceptin is critical for the treatment of Her2-overexpressed metastatic breast cancer.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-10469286, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-10573111, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-11248153, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-11406568, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-11919237, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-12151151, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-12618889, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-12646584, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-12783457, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-1359541, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-15457249, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-15833846, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-16033076, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-16038406, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-16048908, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-16322258, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-16328069, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-16407830, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-16458110, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-16637015, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-16683005, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-16843591, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-16906418, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-17218637, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-17556544, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-17697330, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-2470152, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-2567634, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-2890160, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-9130710, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-9568111, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-9607585, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-9667662, http://linkedlifedata.com/resource/pubmed/commentcorrection/18834540-9761114
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100967800
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/HSP27 Heat-Shock Proteins, http://linkedlifedata.com/resource/pubmed/chemical/HSPB1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Heat-Shock Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2, http://linkedlifedata.com/resource/pubmed/chemical/trastuzumab
pubmed:status	MEDLINE
pubmed:issn	1471-2407
pubmed:author	pubmed-author:JangSang-GeunSG, pubmed-author:KangKeon WookKW, pubmed-author:KangSe HunSH, pubmed-author:KimKyung-HeeKH, pubmed-author:KimSeok-KiSK, pubmed-author:KongSun-YoungSY, pubmed-author:KwonBumiB, pubmed-author:LeeEun SookES, pubmed-author:LeeHo-YoungHY, pubmed-author:YooByong ChulBC
pubmed:issnType	Electronic
pubmed:volume	8
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	286
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:18834540-Antibodies, Monoclonal, pubmed-meshheading:18834540-Antibodies, Monoclonal, Humanized, pubmed-meshheading:18834540-Antineoplastic Agents, pubmed-meshheading:18834540-Breast Neoplasms, pubmed-meshheading:18834540-Cell Line, Tumor, pubmed-meshheading:18834540-Drug Resistance, Neoplasm, pubmed-meshheading:18834540-Enzyme Stability, pubmed-meshheading:18834540-HSP27 Heat-Shock Proteins, pubmed-meshheading:18834540-Heat-Shock Proteins, pubmed-meshheading:18834540-Humans, pubmed-meshheading:18834540-Neoplasm Metastasis, pubmed-meshheading:18834540-Neoplasm Proteins, pubmed-meshheading:18834540-Receptor, erbB-2, pubmed-meshheading:18834540-Up-Regulation
pubmed:year	2008
pubmed:articleTitle	Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability.
pubmed:affiliation	Research Institute and Hospital, National Cancer Center, Republic of Korea. neology7@ncc.re.kr
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't